GE HealthCare management to present at upcoming investor conferences

GEHC 11.25.2024

SERA-AI Powered Highlights
Date of Upcoming Event:2024-12-10
Name of Upcoming Event:Nasdaq Investor Conference
Date of Upcoming Event:2025-01-14
Name of Upcoming Event:43rd Annual J.P. Morgan Healthcare Conference
Full Press ReleaseSEC FilingsOur GEHC Tweets

About Gravity Analytica

Recent News

  • 01.15.2025 - University of California San Francisco and GE HealthCare Launch a Joint Research Program to Drive Innovations in Imaging, Brain Health and Precision Oncology
  • 01.14.2025 - Sutter Health and GE HealthCare enter strategic partnership to benefit patients, physicians and clinicians with advanced, AI-powered imaging
  • 12.12.2024 - GE HealthCare to announce fourth quarter and full year 2024 results on February 13, 2025

Recent Filings

  • 12.12.2024 - 8-K Current report

CHICAGO--(BUSINESS WIRE)--Nov. 25, 2024--GE HealthCare(Nasdaq: GEHC) is announcing that members of its management team will present at the following upcoming investor conferences.

  • Nasdaq Investor ConferenceinLondon, England-December 10, 2024at11:00 am GMT/5:00 am CT/6:00 am ET
  • 43rdAnnualJ.P. Morgan Healthcare ConferenceinSan Francisco, CA-January 14, 2025at4:15 pm CT/5:15 pm ET

Webcasts of these events can be accessed at theGE HealthCarewebsite:https://investor.gehealthcare.com/news-events/eventson the dates and times listed above.

AboutGE HealthCare Technologies Inc.

GE HealthCareis a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated to providing integrated solutions, services, and data analytics to make hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 125 years,GE HealthCareis advancing personalized, connected, and compassionate care, while simplifying the patient’s journey across the care pathway. Together our Imaging, Advanced Visualization Solutions, Patient Care Solutions, andPharmaceutical Diagnosticsbusinesses help improve patient care from diagnosis, to therapy, to monitoring. We are a$19.6 billionbusiness with approximately 51,000 colleagues working to create a world where healthcare has no limits.

Follow us onLinkedIn,X,Facebook,Instagram, andInsightsfor the latest news, or visit our websitehttps://www.gehealthcare.comfor more information.

View source version onbusinesswire.com:https://www.businesswire.com/news/home/20241125654073/en/

GE HealthCare Investor Contact:Carolynne Borders(631) 662-4317carolynne.borders@gehealthcare.com

GE HealthCare Media Contact:Jennifer Fox(414) 530-3027jennifer.r.fox@gehealthcare.com

Source:GE HealthCare

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com